Neurotoxicity of Platinum Compounds in Rats
Author Information
Author(s): D Screnci, HM Er, TW Hambley, P Galettis, W Brouwer, MJ McKeage
Primary Institution: The University of Auckland School of Medicine
Hypothesis
The peripheral sensory neurotoxicity of ormaplatin and oxaliplatin could vary in relation to the enantiomeric configuration of the DACH ligand and their extensive biotransformation.
Conclusion
R,R enantiomers of Pt(DACH) derivatives induce peripheral sensory neurotoxicity at significantly lower cumulative doses and earlier times than S,S enantiomers.
Supporting Evidence
- R,R enantiomers induced neurotoxicity at lower cumulative doses than S,S enantiomers.
- Neurotoxicity was assessed by measuring sensory nerve conduction velocity.
- Body weight changes were significantly greater in rats treated with R,R enantiomers.
Takeaway
Some medicines can be made in different forms, and one form can be more harmful than another. This study found that one version of a medicine caused more nerve problems in rats than another version.
Methodology
Rats were treated with R,R or S,S enantiomers of Pt(DACH) compounds, and their sensory nerve conduction velocity was measured over 8 weeks.
Limitations
The study was conducted in rats, which may not fully replicate human responses.
Participant Demographics
Inbred female Wistar rats, 10 weeks old, weighing 210-240 g.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website